Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial.
about
Time to change the blind men and the elephant approach to Parkinson disease?Anti-Oxidants in Parkinson's Disease Therapy: A Critical Point of ViewPioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial.Sex Differences in Clinical Features of Early, Treated Parkinson's Disease.Bayesian multivariate augmented Beta rectangular regression models for patient-reported outcomes and survival data.Association Between Change in Body Mass Index, Unified Parkinson's Disease Rating Scale Scores, and Survival Among Persons With Parkinson Disease: Secondary Analysis of Longitudinal Data From NINDS Exploratory Trials in Parkinson Disease Long-term SThe effectiveness of creatine treatment for Parkinson's disease: an updated meta-analysis of randomized controlled trialsA Bayesian mathematical model of motor and cognitive outcomes in Parkinson's diseaseCaffeine and Progression of Parkinson Disease: A Deleterious Interaction With CreatineParkinson's Disease and Its Management: Part 3: Nondopaminergic and Nonpharmacological Treatment Options.Understanding the susceptibility of dopamine neurons to mitochondrial stressors in Parkinson's disease.Creatine as a Novel Treatment for Depression in Females Using Methamphetamine: A Pilot StudyCurrent Pharmaceutical Treatments and Alternative Therapies of Parkinson's Disease.Augmented Beta rectangular regression models: A Bayesian perspectivePredictors of weight loss in early treated Parkinson's disease from the NET-PD LS-1 cohort.The CREST-E study of creatine for Huntington disease: A randomized controlled trial.Outcome measurement in neurodegenerative disease: attributes, applications & interpretation.Advances in clinical trials for movement disorders.A predictive model to identify Parkinson disease from administrative claims data.Decade in review-movement disorders: tracking the pathogenesis of movement disorders.Creatine for neuroprotection in neurodegenerative disease: end of story?Therapeutic approaches in Parkinson's disease and related disorders.Beyond muscles: The untapped potential of creatine.Potential of creatine or phosphocreatine supplementation in cerebrovascular disease and in ischemic heart disease.New and emerging medical therapies in Parkinson's disease.Structural correlates of the creatine transporter function regulation: the undiscovered country.Communicating with participants during the conduct of multi-center clinical trials.Caffeine, creatine, GRIN2A and Parkinson's disease progression.Current and experimental treatments of Parkinson disease: A guide for neuroscientists.Creatine and creatine forms intended for sports nutrition.Precision medicine for disease modification in Parkinson disease.Metabolic Dysfunction in Parkinson's Disease: Bioenergetics, Redox Homeostasis and Central Carbon Metabolism.The role of Ca2+ signaling in Parkinson's disease.Targeting urate to reduce oxidative stress in Parkinson disease.Predictors of Functional Decline in Early Parkinson's Disease: NET-PD LS1 Cohort.Cognitive function in 1736 participants in NINDS Exploratory Trials in PD Long-term Study-1.Autonomic and electrocardiographic findings in Parkinson's disease.Longer Duration of MAO-B Inhibitor Exposure is Associated with Less Clinical Decline in Parkinson's Disease: An Analysis of NET-PD LS1.Association of metabolic syndrome and change in Unified Parkinson's Disease Rating Scale scores.Mitochondrial DNA depletion by ethidium bromide decreases neuronal mitochondrial creatine kinase: Implications for striatal energy metabolism.
P2860
Q27693350-E14B74B6-C3FE-4533-869D-68B99CA66E15Q28084254-BC378586-C120-4A29-A0F4-2CD73CE42BACQ30357397-4266EF00-1D6A-40EE-9F4D-7C4FE9420F93Q30375563-701E2609-0BA6-477E-B7ED-4A7761EA810BQ30964183-3BA79885-11B7-414F-A941-3A4F26BC4D15Q31036167-FDC42329-23ED-43D1-93CB-EB280BEF73CCQ33760040-9CB2CEAF-16CD-49FA-AADF-538AB8B49267Q33788172-BED9FB8A-E870-4E07-AD49-61FAA6084435Q36070544-0284C69F-9B1B-49D9-83A7-87E1352574A1Q36164724-70A89106-5DEA-4A4B-B371-87FC147B896BQ36372732-4D371E7F-50A8-4C0F-A3D5-03F5CB86BDBFQ36387048-846C8100-54B8-4E67-843E-3FD86BBCE227Q36925905-B1F2F8D1-D93F-4068-B883-E20564789B54Q37340669-9239065C-B1BA-494D-B6A0-B96F593055F3Q38373893-F97EB4CB-FFEA-4BA8-A461-2A0A016FEC2CQ38374092-D4383E2D-26EE-48F7-9589-08575C121EB4Q38570993-BEAF338C-4E6B-4049-A578-B97AF70E1714Q38573937-56E88897-C2F2-4D3E-A406-F10B2C476E49Q38597211-691575D5-C83B-4EC7-A82E-288D722A028BQ38616824-FDB45381-16B9-4570-9CFD-E185072421B3Q38691246-8CD8C96F-7962-4631-84E8-F056CEA1C52FQ38691406-DCE44B8B-FF39-41FF-AB4E-039EE3515395Q38700215-3C336658-58ED-46DC-99D2-3A7DDE0059CEQ38706110-E24E0765-22A0-4AA5-BAF4-F8A26C9BE0B9Q38718194-80F193E0-F204-48CF-AECB-992F632C5F3BQ38764046-A5308A0D-232C-4480-B9B5-D26159CE6ABAQ38826602-E06B2C4D-24DC-419C-A902-C42F2494665CQ38893103-EE60BF89-68DB-4B8F-997A-321541D4F380Q38941557-8F10CECF-0988-4ACD-87A2-DA585FA7B41FQ39055380-64370D8F-23EF-4CC2-9429-DBF155CCBE81Q39096323-1CC419AF-D4C1-460E-B00C-074DB5E39526Q39199926-A8188EA1-FC52-4F1E-AD77-68776B937F0FQ39281423-05848A3B-8150-4526-89FF-18AD89382358Q39379023-DA4F174C-3F6C-460C-9D77-C421BD35A188Q40240247-315E966B-BD05-4A82-A5C9-411D31F8A305Q40540982-CF885DA8-AC76-4FE0-A6B6-396A414744E5Q45228075-CBCEBDEF-054B-4302-A9CE-A0D3D2D4B3BEQ46004015-D52600A4-C90D-46DF-8330-0EABCDEFD93CQ46184142-1D897FF0-3F12-4249-9782-2DC5EF4F6816Q47233980-E4E01C81-2E83-4E13-B592-C2B26F380C44
P2860
Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial.
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Effect of creatine monohydrate ...... : a randomized clinical trial.
@ast
Effect of creatine monohydrate ...... : a randomized clinical trial.
@en
type
label
Effect of creatine monohydrate ...... : a randomized clinical trial.
@ast
Effect of creatine monohydrate ...... : a randomized clinical trial.
@en
prefLabel
Effect of creatine monohydrate ...... : a randomized clinical trial.
@ast
Effect of creatine monohydrate ...... : a randomized clinical trial.
@en
P2093
P2860
P50
P356
P1476
Effect of creatine monohydrate ...... : a randomized clinical trial.
@en
P2093
Alicia H Augustine
Anne-Marie Wills
Barbara C Tilley
Carlos Singer
Chadwick W Christine
Chizoba C Umeh
Cornelia Kamp
David J Houghton
David K Simon
Debra Babcock
P2860
P304
P356
10.1001/JAMA.2015.120
P407
P577
2015-02-01T00:00:00Z